Tuesday, July 12, 2022

‘Head-Spinning’: FDA Quietly Grants Full Approval of Pfizer Comirnaty Vaccine for Adolescents



Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free. The U.S. Food and Drug Administration (FDA) on Friday granted full approval of Pfizer-BioNTech’s Comirnaty COVID-19 vaccine for adolescents 12 through 15 years old.

ORIGINAL LINK